Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology

Clinical Trials: Small Cell Lung Cancer

A listing of clinical trials currently looking for volunteers to enroll in Small Cell Lung Cancer studies. Click on the closest city to find more detailed information on a research study in your area.

State

Arizona
California
Connecticut
Delaware
Florida
Georgia
Illinois
Indiana
Maine
Maryland
Massachusetts
Michigan
Missouri
New Jersey
New Mexico
North Carolina
Oregon
Pennsylvania
South Carolina
Tennessee
Texas
Utah

Country

Canada
France
Germany
Hungary
Japan
Korea, Republic of
Norway
Romania
Sweden
United Kingdom

Arizona

Scottsdale : Pinnacle Oncology

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

California

Beverly Hills : Tower Cancer Research Foundation

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Connecticut

Stamford : Medical Oncology Hematology, Stamford Hospital

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Torrington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Delaware

Newark : Helen F. Graham Cancer Center

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Florida

Fort Lauderdale : Holy Cross Hospital

CALGB 30610

Fort Lauderdale : Holy Cross Hospital

Immunogen 007

Miami : VA. Medical Center

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

Georgia

Athens : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Macon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Illinois

Elk Grove Village : Alexian Brothers Hospital Network

A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) - IIIA Non-Small Cell Lung Cancer (NSCLC).

Elk Grove Village : Alexian Brothers Hospital Network

E1508 A Randomized Phase II Study of Cisplatin and Etoposide In Combination with Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients with Extensive Stage Small Cell Lung Cancer

Chicago : Northwestern University Feinberg School of Medicine

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Chicago : Northwestern University

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Indiana

Bloomington : Cancer Care Center of Southern Indiana

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Evansville : Oncology Hematology Associates of SW Indiana

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Fort Wayne : Fort Wayne Oncology & Hematology, Inc

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Indianapolis : IN Onc/Hem Associates

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Indianapolis : St. Vincent Hospital & Health Centers

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Indianapolis : Indiana University Simon Cancer Center

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Lafayette : Horizon Oncology Researcg

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Lafayette : IU Health Arnett Cancer Center

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Muncie : IU Health at Ball Memorial Hospital

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Munster : Monroe Medical Associates

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

South Bend : Northern Indiana Cancer Research Consortium

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Terre Haute : Providence Medical Group

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Maine

Scarborough : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Maryland

Baltimore : University of Maryland Greenebaum Cancer Center

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Massachusetts

Boston : Beth Israel Deaconess Medical Center

Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer

Boston : Dana Farber Cancer Institute

Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer

Boston : Massacusetts General Hospital

Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer

Michigan

Detroit : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Eastpointe : Kelly Family Medical Center, PC

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

Missouri

Bridgeton : St.Louis Cancer Care, LLP

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

St. Joseph : Heartland Regional Medical Center

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

New Jersey

Cherry Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Hackensack : Haceknasack University Medical Center

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Mt. Holly : Hematology Oncology Associates S.J., P.A.

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

New Mexico

Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

North Carolina

Durham : Duke University Medical Center

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Oregon

Portland : Providence Portland Medical Center

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Pennsylvania

Hershey : Penn State College of Medicine, Penn State Milton S. Hershey Medical Center

Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer

Philadelphia : Pennsylvania Oncology-Hematology Associates

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

South Carolina

Charleston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Tennessee

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Small-Cell Lung Cancer

Nashville : The Sarah Cannon Research Institute

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Texas

Houston : MD Anderson Cancer Center

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

San Antonio : South Texas Accelerated Research Therapeutics (START)

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Utah

Salt Lake City : Huntsman Cancer Institute

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Canada

Oshawa : Investigational Site Number 124002 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer